Webinar: Anti-Corruption Compliance in Pharma and Medical Device Industries

FCPA enforcement against drug and device companies continues at a robust rate. Given the high-risk nature of pharmaceutical and medical device industries and significant interactions with foreign government officials, drug and device companies face a number of challenges in designing and implementing effective anti-corruption compliance programs. 

Join Michael Volkov, CEO at The Volkov Law Group, as he discusses recent trends and compliance issues facing drug and device companies in the global marketplace.

Leave a Reply

Your email address will not be published. Required fields are marked *